Medical Genetics & Genomics — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match, workforce, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-26.

Also called: medical genetics, clinical genetics, genetics & genomics. A small base specialty with multiple entry routes: you can enter it straight from medical school as a categorical resident, add it after another residency (pediatrics, internal medicine, OB/GYN), or train in a combined dual-board program. Scope: the diagnosis and management of inherited and genomic disease across every organ system and every age, from prenatal to adult.

The 30-second version

Medical genetics is the specialty of the genome, the doctors who diagnose and manage inherited and genetic disease, interpret genomic testing, and care for families rather than just individuals. They work up the child with unexplained developmental delay and unusual features (dysmorphology), manage inborn errors of metabolism, run hereditary-cancer clinics, counsel prospective parents about reproductive risk, and increasingly read whole-genome and whole-exome sequencing to put a name to conditions that used to be diagnostic dead ends. It is one of the smallest physician specialties in the country, one of the most intellectually distinctive, one of the most accessible to match into, and, honestly, one of the lowest-paid. That last tension is the whole personality of medical genetics: a field being transformed by the genomics revolution while sitting near the bottom of the physician pay scale. It is the thing a premed most needs to understand before falling in love with it.123

Quick dashboard (details and sources below)
Training after med school 2–4 years, depending on the route (see below)
Total from college start ~10–12 years (4 undergrad + 4 med school + 2–4 residency)
Entry routes / training chain Categorical from med school; 2-yr genetics after another residency; combined dual-board programs (Peds–Genetics, IM–Genetics, Med-Peds–Genetics, MFM/REI–Genetics)
Competitiveness Low — a small field that frequently underfills; comparatively accessible ⟳
Typical full-time pay ~$250,000–$300,000 — among the lowest of any physician specialty ⟳
Lifestyle Outpatient, cognitive, largely controllable; low acute call; good longevity
Burnout 34.7% report some burnout — but that is the whole genetics workforce (n=3,070), of whom only 15.4% were clinical geneticists, so it is not a physician figure ⟳
% women ~59% of clinical geneticists (2019); ~85% of a broader 2023 genetics-workforce survey ⟳
DO / IMG accessibility Small field, real IMG entry point; DO representation limited ⟳

What they actually do

Medical geneticists are the physicians a hospital calls when a diagnosis doesn't fit any single organ system: when a child isn't growing or developing as expected, when a family has a pattern of early cancers or sudden cardiac deaths, when a newborn screen comes back abnormal, or when a prospective parent wants to understand a reproductive risk. The core skill is diagnostic reasoning across the whole genome and the whole family rather than any procedure: taking a detailed three-generation history, recognizing patterns of physical features (dysmorphology), choosing and interpreting the right genetic or genomic test, and translating a complex molecular result into a diagnosis, a management plan, and a conversation a family can actually use.14

The work sorts into a few recognizable domains. Pediatric dysmorphology and general genetics handles congenital anomalies, developmental delay, and syndromic diagnosis. Biochemical and metabolic genetics takes inborn errors of metabolism and newborn-screening follow-up, including conditions like PKU and urea-cycle disorders, some of the few genetic conditions with real, time-sensitive treatments. Cancer genetics covers hereditary cancer syndromes (BRCA, Lynch, and more), risk assessment, and cascade testing of relatives. Prenatal and reproductive genetics is carrier screening, prenatal diagnosis, and counseling around reproductive options. And a fast-growing genomic medicine / pharmacogenomics layer that increasingly cuts across all of these as sequencing gets cheaper.14

Two things distinguish the day-to-day. First, it is heavily cognitive: long new-patient visits, often an hour or more, meticulous chart and literature review, and multidisciplinary conferences rather than a procedure list. Second, geneticists work shoulder-to-shoulder with genetic counselors, the master's-trained professionals who do much of the pre- and post-test counseling; the physician's role centers on diagnosis, medical management, complex-result interpretation, and the pieces that require an MD.13

A day in the life (outpatient clinical genetics): a clinic of a few long new-patient consults rather than a packed board. A toddler with developmental delay and subtle dysmorphic features, an adult with a strong family cancer history, a metabolic-disorder follow-up. Between visits: reviewing records and the literature, deciding which test to send (a targeted panel? an exome? a chromosomal microarray?), and later interpreting results that may come back as a clear answer, a "variant of uncertain significance," or nothing at all. Much of the work is thinking, reading, and explaining. There's usually little to no overnight acute call in outpatient genetics; the intensity is intellectual and emotional rather than physical.13

The training path & time to completion

This is the section that most sets medical genetics apart, because there is no single path. There are several, and which one you choose depends on when you decide and what else you want to be certified in. All routes lead to certification by the American Board of Medical Genetics and Genomics (ABMGG), the specialty's board.1

The core routes into clinical genetics:

  • Categorical, from medical school. You can match into a categorical Clinical Genetics & Genomics residency straight out of med school. Because ABMGG requires at least one year of broad clinical training (with ≥12 months of direct patient care) plus two years of medical genetics, a categorical program entered from med school folds these together and typically runs about four years.1 ⟳
  • Two-year genetics after another residency. If you first complete (or nearly complete) a residency in another field, most commonly pediatrics, internal medicine, or OB/GYN, you can then do a 2-year medical genetics residency and become board-eligible in genetics. This "add it on later" route is how many geneticists arrive, and it lets you carry a second board.1
  • Combined dual-board programs. Several programs offer combined tracks that grant certification in genetics and a partner specialty: Pediatrics–Genetics, Internal Medicine–Genetics, Med-Peds–Genetics, and reproductive combinations such as Maternal-Fetal Medicine–Genetics and Reproductive Endocrinology & Infertility–Genetics. These are typically four to six years depending on the pairing.1

The lab-based and biochemical tracks (a different flavor of the field):

  • Laboratory Genetics & Genomics (LGG). A lab-based certification (open to MDs, DOs, and PhDs) for those who direct clinical genetics/genomics laboratories: cytogenomics, molecular testing, and genome interpretation. This is a real and growing branch, and, as Compensation explains, an important higher-paying exit.1
  • Clinical Biochemical Genetics. Laboratory diagnosis of metabolic disease (also open to PhDs).1
  • Medical Biochemical Genetics. A 1-year subspecialty after clinical genetics, for physicians who manage inborn errors of metabolism.1
  • Molecular Genetic Pathology. A 1-year subspecialty bridging genetics and pathology.1

Board: the ABMGG, which certifies the tracks above and requires certification to be renewed over time. Candidates remain board-eligible for a defined window after training.1

Total from the start of college: roughly ~10–12 years: 4 undergrad + 4 med school + 2–4 years of residency depending on the route (longer for combined dual-board programs). Because the routes vary so much, treat any single "total" as approximate.1

How competitive is it?

Short version: medical genetics is one of the least competitive specialties to enter, precisely because it is so small and frequently underfills.

The numbers are tiny. In the NRMP Main Match, the IM–Genetics combined track offers a handful of PGY-1 positions each year, on the order of 3–5 nationally (5 in 2025, 3 in 2026, all filled both years). The Peds–Genetics track is an order of magnitude larger: 31 positions in 2026, of which 27 filled.5 Fill rates bounce around year to year because the denominator is so small: across the last five Main Match cycles the IM–Genetics track has run anywhere from 60% to 100% filled, and the larger Peds–Genetics track between 84% and 96%.56 Most geneticists, though, don't enter through those few PGY-1 slots at all. They come in through the 2-year-after-another-residency route, via the fellowship-style Medical Genetics Match, which is a much larger share of entry and is not a high-bar competition.16

What that means for you today:

  • It is genuinely accessible. Interest in the field is limited enough that programs often have unfilled capacity; a motivated applicant with real interest in genetics is not fighting the odds you'd face in dermatology or a surgical subspecialty.56 ⟳
  • IMGs are a real entry point. In the small recent categorical cohorts, IMGs have filled a meaningful share (e.g., ~20–33% in recent years); DO representation has been minimal, more a reflection of how few people apply than of a closed door.56 ⟳
  • Clean competitiveness metrics barely exist. With only a few positions a year, published Step-score and applicant-ratio data for genetics are sparse, so treat any such figure as limited data.6 ⟳

The honest read: getting into genetics is not the hard part. The field's central challenge is downstream, in the pay and the workforce economics below, rather than in the match.

Compensation — the honest version

This is the single most important practical fact about the field: medical genetics is consistently among the lowest-paid physician specialties in the United States. It is a cognitive, non-procedural, largely outpatient field whose core work of long diagnostic visits, chart and literature review, counseling, and test interpretation is poorly rewarded by a payment system built around procedures. This is a durable structural pattern, not a bad year.27

National number. Crowdsourced and survey figures put the median for clinical medical geneticists in roughly the $250,000–$300,000 range (SalaryDr's 2026 median is ~$300,000 on a self-selected panel of 17; commercial salary aggregators run lower). In the major specialty rankings, genetics sits down among the lowest-paid fields alongside pediatrics, pediatric subspecialties, infectious disease, and endocrinology, a tier where the top procedural specialties out-earn you by 2× or more. A defensible way to hold it: ~$250K–$300K typical, near the bottom of the physician pay distribution.27 ⟳

Where it sits in the ranking, and the proof. Genetics is the "G" in the well-known Doximity "READING" mnemonic, the cluster of outpatient, non-procedural pediatric subspecialties (Rheumatology, Endocrinology, Adolescent medicine, Developmental-behavioral, Infectious disease, Nephrology, Genetics) that pay at or below general pediatrics (~$265K) despite years of extra training. General pediatrics itself ranks dead last or near-last in Medscape's specialty compensation rankings, and genetics lives in that same basement.7 ⟳

The lab and industry off-ramp, the part premeds don't hear. Clinical genetics may pay poorly, but laboratory genetics and the genomics industry pay meaningfully more. Because genetics uniquely certifies laboratory directors (via Laboratory Genetics & Genomics), and because the entire biotech/diagnostics/precision-medicine sector needs people who can interpret genomes, there is a genuine, well-trodden path from clinical training into molecular diagnostic lab directorship, biotech and pharma medical-director roles, and genomics-company positions, jobs that routinely pay well above clinical genetics and often above the physician median. For a debt-loaded student, this is not a footnote: it means the field has a built-in higher-paying exit that most low-paid specialties lack.8 ⟳

Academic tilt and employment. The great majority of clinical geneticists work in academic medical centers (~73% in the 2019 workforce data), mostly in salaried positions that are predictable and have a modest ceiling. That caps clinical pay but has two offsetting features: it's the natural home of the interesting genomic-medicine work, and academic/non-profit employment is exactly what makes Public Service Loan Forgiveness (PSLF) viable (see the FLI angle). There isn't much "eat-what-you-kill" private-practice upside in a field with few billable procedures, so the higher-paying alternatives are lab directorship and industry.38 ⟳

Lifestyle

Medical genetics is, for most who practice it, one of the more controllable lifestyles in medicine. The work is predominantly outpatient and cognitive, built around scheduled clinics, conferences, and result interpretation rather than shifts, ORs, or floors. Acute overnight call is minimal in most clinical-genetics roles (metabolic emergencies and inpatient consults are the main exceptions), and the laboratory tracks are even more schedule-predictable. The trade-off for the low pay is, genuinely, a humane and largely self-directed week.13

The texture of the load is intellectual and emotional rather than physical: dense diagnostic reasoning, the frustration of uninformative results and "variants of uncertain significance," and the weight of delivering serious diagnoses to families. There's also a real administrative and authorization burden, and fighting insurers for coverage of genetic testing is a recurring grievance.

Lifestyle rating: 4/5. Genuinely more controllable than most of medicine, docked because the emotional weight of the diagnoses and the testing-authorization grind make the "good hours" less relaxed than the raw schedule suggests.

Wellbeing

Burnout: low, on the only survey that covers the field. The 2023 national genetics workforce survey found 34.7% of 3,070 respondents experiencing some burnout, and 94.4% with no plans to leave the field within a year. Read what that population is before you read the number: 66.0% of respondents were genetic counselors and only 15.4% were clinical geneticists, so five-sixths of the sample were not physicians. It is a genetics figure rather than a physician figure, and setting it against a physician-only burnout average would compare two instruments and two populations at once. What it does support is the direction, which the field's structure predicts anyway: controllable hours, high intellectual engagement, and strong mission alignment protect against burnout even when pay is low.9 ⟳

Meaning and satisfaction, the field's quiet strength. Geneticists tend to describe the work as deeply meaningful and intellectually rewarding: solving diagnostic puzzles other specialties can't, giving families answers after long odysseys, and working at the frontier of genomic medicine. The satisfaction here mirrors pediatrics: high on the work itself and the mission, low on the paycheck. (Note: the big commercial "would choose again" and happiness surveys often don't break genetics out separately because the field is so small, so treat specialty-specific happiness figures as limited data.)9 ⟳

Career longevity. Genetics is generally a long-career, sustainable specialty, because the cognitive, outpatient nature and low physical and call burden mean people can practice into their later careers. The workforce data actually show an aging field (average age ~51 in 2019, with a large share nearing retirement), which is a workforce supply problem more than a burnout one. The lab and industry tracks also function as later-career pivots that preserve engagement (and often pay).39

Who's in the field (demographics)

  • Women: clinical geneticists were about 59% women in 2019 (up from 45% in 2003), and a broader 2023 genetics-workforce survey, which pools geneticists with the heavily female genetic-counseling workforce, ran ~85% women. Either way, genetics is a female-majority field and trending more so. (For cross-specialty context, women are ~38% of active physicians overall.)3910 ⟳
  • IMG: in the small recent categorical cohorts, IMGs have filled a meaningful share (~20–33% in some years), a real entry point relative to the field's size.56 ⟳
  • DO: representation has been minimal, largely reflecting how few applicants of any kind the field draws rather than a closed door.56 ⟳
  • Workforce size & distribution: this is genetics' defining demographic fact, because it is tiny and maldistributed. Actively practicing clinical geneticists number in the low four figures nationally (~2 clinical-geneticist FTE per million population). In 2019, ~14 states had five or fewer certified clinical geneticists and one had none, with new-patient waits of months in many places. The field is widely described as facing a workforce shortage even as demand for genomic medicine climbs.3 ⟳
  • URiM: no clean genetics-specific URiM figure was located; the 2023 workforce authors explicitly flag the need to "attract new and diverse individuals"; limited data.9 ⟳

Culture, personality & the online stereotypes

Who gravitates here: the pattern people describe is fairly consistent. Puzzle-solvers and deep thinkers who love diagnostic reasoning, rare disease, and the intellectual pull of the genome; people who are patient, detail-obsessed, and comfortable sitting with uncertainty (a lot of genetics is "we don't know yet"); strong communicators who can explain something genuinely hard to a frightened family; and mission-driven types who value meaning and intellectual richness over income. Many arrive having fallen in love with genetics in a research or lab setting. Plenty of people don't fit any mold, but the "curious, cerebral, family-centered" read comes up again and again.19

The stereotypes. Community caricatures rather than facts, each with an unfair edge:

  • "The smartest doctors in the building / walking encyclopedias." A mostly affectionate reputation rooted in the field's intellectual density, but it flattens the emotional and counseling skill the job actually demands.
  • "They diagnose but can't treat." The old knock that genetics is a "diagnose-and-refer" field. Increasingly untrue, since metabolic management, gene therapies, and targeted treatments are all growing, but the reputation lingers because so many genetic conditions still lack a cure.
  • "Basically research/lab people who see a few patients." Reflects the field's heavy academic and lab presence, and unfair to the many who run busy clinical practices.
  • "The lowest-paid specialty, so it must be for people who don't care about money." Rooted in a real pay gap, but the "martyr" framing is unfair. Geneticists are clear-eyed about the economics, and many deliberately use the field's lab and industry exits.

What people say online (synthesized and paraphrased, not quotes): across trainee and physician forums, and specialty threads, the dominant themes are (1) love of the intellectual work, the diagnostic puzzles and the frontier feel of genomics, paired with (2) candid worry about pay relative to modern debt, and (3) frustration with insurance authorization for testing and with being under-resourced. A recurring, more hopeful thread is genomics-revolution optimism: the sense that cheap sequencing and precision medicine are pulling genetics from the margins toward the center of medicine. People also consistently point newcomers toward the lab and industry tracks as the way to reconcile the work they love with a livable income.9

Voices from the field. Paraphrased from public writing, with links to the originals:

  • The 2019 and 2023 US medical-genetics workforce studies document the field's defining paradox: rising demand for genomic medicine against a small, aging, geographically concentrated physician workforce with long patient waits, a shortage the authors argue threatens access to genetic care.39
  • Doximity's pediatric-subspecialty compensation commentary places genetics in the "READING" cluster of fields that pay at or below general pediatrics despite extra training, naming the pay problem plainly.7
  • Career-guidance writing on genomics repeatedly highlights the laboratory-director and biotech/industry pathways as the field's higher-paying, fast-growing frontier.8

Why people choose it / why people leave

Why choose it: the work is unusually intellectual and meaningful, and you solve diagnostic puzzles and give families answers after long odysseys · you work at the frontier of genomic medicine, arguably the fastest-moving area in medicine · controllable, largely outpatient lifestyle with minimal acute call · low burnout across the genetics workforce and long career longevity · accessible to match into, including via multiple entry routes and as a second board · a built-in higher-paying lab/industry off-ramp most low-paid fields don't have · strong PSLF fit at academic centers.

Why leave or avoid it: pay is among the lowest in medicine, a serious concern against six-figure debt · many genetic conditions still can't be treated, which some find frustrating · heavy reliance on insurers approving expensive testing · a small, academic-heavy job market concentrated in a handful of centers, with few jobs in many states · the field's core work (delivering hard diagnoses, sitting with uncertainty and "variants of uncertain significance") is emotionally and intellectually demanding.

Best fit if: you're energized by diagnostic reasoning, rare disease, and the genome itself · you define career success by intellectual richness and impact more than income · you communicate warmly and can explain hard things to families · you value a controllable outpatient schedule · you're open to lab or industry work as part (or all) of your career.

Not for you if: you need a high income to service large debt quickly · you want a highly procedural or acute, hands-on field · you'd be frustrated by often diagnosing without curing, or by fighting insurers over testing · you want a large, geographically flexible job market · you dislike deep uncertainty and open-ended answers.

The FLI angle — Medical Genetics for first-gen, low-income & immigrant students

Medical genetics is one of the more two-sided FLI stories in medicine, so read both halves squarely.

Where genetics fits FLI realities well:

  • It's accessible. This is a field you can realistically match into without an elite research machine behind you, and there are multiple doors in: straight from med school, after another residency, or as a combined program. For a first-gen or immigrant student without a pedigree, that accessibility is a genuine advantage, not a footnote. IMGs, in particular, are a real presence in the small entering cohorts.56
  • The mission fit is direct and the work is deeply meaningful. If you're drawn to solving problems no one else can and to serving families with rare, under-diagnosed conditions, often in under-resourced communities that lack any genetics access at all, the field is naturally aligned.3
  • The employer will almost always qualify for PSLF. The loan is the part to check. Because most clinical geneticists work at academic and non-profit centers, nearly any job you take is a Public Service Loan Forgiveness employer, which is a genuine structural advantage of the field. What PSLF discharges is the federal balance, on ten years of qualifying payments on an income-driven plan. Since July 2026 the federal system stops lending at $200,000, and medical school costs more than that at almost every school, so a reader starting now graduates with a private loan alongside the federal one and no program forgives the private half. That is the part that bites hardest here rather than least: a private loan sets its payment from the balance rather than from your income, so it does not shrink to fit a $250–300K salary the way an income-driven federal payment does, and this is one of the lowest-paid fields in medicine. PSLF is a real lever on one loan, not an answer to the pay gap. Price the two loans separately before you let it settle the decision.
  • The higher-paying exit is real. Unlike most low-paid specialties, genetics has a built-in lab-directorship and biotech/genomics-industry path that pays meaningfully more. For a debt-loaded student, knowing there's a legitimate higher-income door, without leaving the field you trained in, genuinely changes the math.8

The honest concern, not sugarcoated:

  • You would be choosing one of the lowest-paid specialties. For a student carrying ~$200K+ in loans with no family financial safety net, choosing a field near the bottom of the pay scale is a material risk rather than only a values choice. You may be supporting family, unable to lean on parents in an emergency, and servicing large debt on a ~$250–300K salary. This is one of the places where "follow your heart" advice can be genuinely costly, and it deserves a hard look and a real debt plan before you commit.
  • The job market is small and concentrated. Most jobs are at academic centers in a limited set of cities; if family, status, or geography ties you to a particular place, the number of genetics positions there may be very small, so weigh that seriously.
  • The lab/industry exit is a plan, not a guarantee. The higher-paying roles are real but competitive and often require the lab-genetics track or additional positioning. Treat it as a path to build deliberately rather than a fallback that appears on its own.

Bottom line: medical genetics can be an intellectually thrilling, mission-rich, and genuinely reachable field for an FLI student, but it sits near the bottom of the pay scale in a small, academic-heavy job market. Go in with eyes open: build the PSLF plan, understand the lab/industry off-ramp, and run the debt math as seriously as the calling. Both things are true at once.

Sub-subspecialties & fellowships

This is one of the more branched fields in medicine, and unusually, several of its tracks are open to PhDs as well as physicians.

  • Laboratory tracks. Clinical molecular genetics, clinical cytogenetics and clinical biochemical genetics are laboratory-director pathways, and the PhD-accessible ones.
  • Metabolic and biochemical practice. The clinical side of inherited metabolic disease, which is where much of the acute inpatient work sits.
  • Molecular genetic pathology. A joint subspecialty with pathology, and the clearest bridge between the clinic and the laboratory.
  • The laboratory and industry route is the higher-paying frontier. Diagnostics companies and laboratory directorships pay differently from clinic-based genetics, and that gap is one of the field's defining economic facts.

Fun facts

  • Medical genetics is one of the smallest physician specialties in the US, with actively practicing clinical geneticists numbering in the low four figures, and some states have five or fewer certified clinical geneticists (one state has had none).
  • It's the specialty with the most entry routes: straight from med school, added after pediatrics, IM, or OB-GYN, or via combined dual-board programs, plus lab tracks open to PhDs rather than physicians only.
  • It's the "G" in "READING," the cluster of outpatient subspecialties that can pay at or below general pediatrics despite years of extra training, one of medicine's stranger pay inversions.
  • It may be the low-paid specialty with the best-defined higher-paying exit, since laboratory directorship and the biotech and genomics industry actively recruit its trainees.
  • It's a female-majority field (~59% of clinical geneticists in 2019) and an aging one, with a documented workforce shortage as genomic-medicine demand climbs.
  • Its scientific ground is moving faster than almost any field in medicine: the plummeting cost of genome sequencing has, in a single generation, turned genetics from a diagnostic last resort into a frontier of precision medicine.

Sources

Footnotes

  1. ABMGG certification pathways and training routes — categorical clinical genetics & genomics residency (the required clinical year + 2 years genetics), the 2-year sequential route after another ACGME residency, combined dual-board programs (Peds–Genetics, IM–Genetics, MFM–Genetics, REI–Genetics), and the laboratory/biochemical tracks (Laboratory Genetics & Genomics, Clinical Biochemical Genetics, Medical Biochemical Genetics, Molecular Genetic Pathology). American Board of Medical Genetics and Genomics, "Certification Pathways" and "Exam Requirements" (accessed 2026). https://www.abmgg.org/initial-certification/certification-pathways/ ; https://www.abmgg.org/initial-certification/certification-exam/exam-requirements/ ; program-structure example: Johns Hopkins Clinical Genetics Residency (https://www.hopkinsmedicine.org/genetic-medicine/education-training/clinical-genetics-residency-program/residency-program). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18

  2. Medical genetics compensation — median in the ~$250K–$300K range; among the lowest-paid physician fields. SalaryDr, "U.S. Medical Genetics Physician Salary 2026" (median ~$300K, small crowdsourced sample; 10th–90th ~$235K–$335K) (https://www.salarydr.com/specialty/medical-genetics); Med School Insiders, "Lowest Paid Medical Specialties" (2026) (https://medschoolinsiders.com/pre-med/lowest-paid-medical-specialties/). ⟳ SalaryDr panel size: n=17. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. ↩ ↩2 ↩3

  3. 2019 US medical-genetics workforce — ~59% women (up from 45% in 2003), average age ~51.4, ~73% in academic centers, ~2 clinical-geneticist FTE per million population, 14 states with ≤5 certified clinical geneticists (one with none), long patient waits, documented shortage; scope and practice setting. Maiese et al., "The 2019 US medical genetics workforce: a focus on clinical genetics," Genetics in Medicine (2021). https://www.nature.com/articles/s41436-021-01162-5?error=cookies_not_supported&code=bd84139d-31b1-4ad3-aeeb-fae7e993a4c6 ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10

  4. Scope of clinical genetics practice — dysmorphology, inborn errors of metabolism, hereditary cancer genetics, prenatal/reproductive genetics, pharmacogenomics, and the ordering/interpretation of genetic and genomic testing alongside genetic counselors. ACMG, "Careers in Medical Genetics" (https://www.acmg.net/ACMG/Education/Student/Careers_in_Medical_Genetics.aspx); NHGRI/genome.gov Medical Genetics Residency Program overview (https://www.genome.gov/careers-training/research-training/Medical-Genetics-Residency-Program). ↩ ↩2

  5. NRMP Main Residency Match, medical genetics combined-pathway positions. The Main Match has no standalone medical genetics specialty; it carries exactly two genetics rows, Medicine-Medical Genetics and Pediatrics-Medical Genetics, both combined tracks. Medicine-Medical Genetics: 5 positions offered and 5 filled in 2025, 3 and 3 in 2026, and across the five cycles 2022–2026 its fill rate runs 60%, 75%, 100%, 100%, 100%. Pediatrics-Medical Genetics: 28 offered and 27 filled in 2025, 31 and 27 in 2026, with five-year fill between 84% and 96%. NRMP, Results and Data: 2026 Main Residency Match, May 2026, Table 1 and the five-year PGY-1 trend table (https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf); NRMP, "2025 Main Residency Match: Match Rates by Specialty and State" (2025) (https://www.nrmp.org/wp-content/uploads/2025/03/Main_Match_Results_by_State_Specialty_and_AppType_2025.pdf). The separate, fellowship-style Medical Genetics Match runs through NRMP's Specialties Matching Service and fills far lower: 45.0% in 2026, 51.2% in 2025, 41.2% in 2024, 45.7% in 2023, 44.2% in 2022 (https://www.nrmp.org/wp-content/uploads/2026/02/SMS_Results_and_Data_Report2026.pdf). Corrected 2026-08-17: this footnote called the 5-and-3 pair "categorical PGY-1" positions and the body called the 60%-to-100% range "recent categorical cycles." Both are the Medicine-Medical Genetics combined track, which the body already named correctly a sentence earlier. No categorical medical genetics row exists in the Main Match, so a reader checking the word "categorical" against NRMP would have found nothing. ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  6. Medical genetics application/match trends and accessibility (small field, frequent underfill, 2-year-after-residency as the larger entry route, sparse competitiveness metrics, IMG share). Genetics in Medicine, "Medical genetics and genomics residency programs: Trends in applications, match rates, and matriculation from 2015 to 2024" (2025) (https://www.sciencedirect.com/science/article/abs/pii/S1098360025002825); NRMP Medical Genetics Match (https://www.nrmp.org/fellowship-applicants/participating-fellowships/medical-genetics-match/). ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8

  7. Genetics as the "G" in Doximity's "READING" cluster of outpatient (pediatric) subspecialties paying at/below general pediatrics (~$265K), which itself ranks last/near-last in Medscape's specialty compensation rankings. Doximity Op-Med, Satyan Lakshminrusimha, "The Salary Problem in Pediatric Subspecialties" (2024/2025) (https://opmed.doximity.com/articles/the-salary-problem-in-pediatric-subspecialties); Doximity 2025 Physician Compensation Report (https://www.doximity.com/reports/physician-compensation-report/2025). ⟳ ↩ ↩2 ↩3 ↩4

  8. Higher-paying laboratory-genetics and biotech/genomics-industry pathways as a real off-ramp (lab directorship via Laboratory Genetics & Genomics; medical-director and diagnostics/biotech roles). George Washington University, "Examining Medical Genetics and Molecular Biology Career Paths" (https://healthsciencesprograms.gwu.edu/news/examining-medical-genetics-and-molecular-biology-career-paths); ScienceJournal, "Highest Paying Genetics Jobs" (2026) (https://www.scijournal.org/articles/highest-paying-genetics-jobs); ACMG, "Careers in Medical Genetics" (https://www.acmg.net/ACMG/Education/Student/Careers_in_Medical_Genetics.aspx). Corrected 2026-08-17: the FLI section's PSLF bullet asserted the outcome — "ten years of qualifying payments on an income-driven plan, then tax-free forgiveness" — and called PSLF "arguably the single most important lever" against the field's low pay, with no federal-versus-private distinction. Under the rule Saad set on 2026-08-16, PSLF forgives federal loans only, the federal system stops at $200,000 from July 2026, and a private loan's payment is set by its balance rather than by income, which makes it the part of the debt that does not ease on one of the lowest physician salaries in medicine. The bullet now states the employer-eligibility fact, which is the strong and checkable half, and names the private-loan trap. The remaining PSLF mentions on this page are employer-eligibility claims and are unchanged. ⟳ ↩ ↩2 ↩3 ↩4

  9. 2023 US medical-genetics workforce. "The 2023 medical genetics workforce in the United States," Genetics in Medicine (2025), https://pubmed.ncbi.nlm.nih.gov/40421625/ ; https://www.sciencedirect.com/science/article/abs/pii/S109836002500108X. Read in full: "Of the 3070 medical genetics professionals who responded, 66.0% were genetic counselors, 15.4% were clinical geneticists, 12.2% were laboratory geneticists, 4.7% were metabolic dietitians, and 1.7% were genetic nurses or physician assistants. The respondents identified as White (76.1%) and women (84.7%) … Despite 34.7% of respondents experiencing some burnout, most had no plans to leave the field (94.4%) within the next year." Corrected 2026-08-17: this footnote and the dashboard and wellbeing sections set the 34.7% against "the ~49% all-physician average" and concluded genetics burnout is below the physician average. The survey's population is five-sixths non-physician, so it cannot carry that comparison, and setting it against a physician-only instrument's baseline is the cross-instrument error this site's burnout rule exists to police. The figure is kept and relabeled as a whole-workforce measurement, the respondent breakdown is now stated wherever it is used, and the comparison to a physician average is gone. The dashboard had also called n=3,070 a "small workforce survey," which it is not; the field is small, the survey is not. ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8

  10. Cross-specialty context — women ~38% of active US physicians; genetics is a female-majority field. from AAMC Physician Specialty Data Report (2021/2022) (https://web.archive.org/web/20250112142220/https://www.aamc.org/data-reports/workforce/data/active-physicians-sex-specialty-2021). ⟳ ↩

Researched with AI assistance and reviewed by hand. How this site is made